Sort
82,697 grants matching “vaccine development”
Core 3: Non-human Primate Core
$2,798,848Barton F Haynes · Duke University · P01 · FY2023 · AI
NIDCD Core for Clinical Research and Care
$2,798,488Clint Allen · National Institute On Deafness And Other Communication Disorders · ZID · FY2022 · DC
LOC: HIV Vaccine Trials Network
$2,797,660Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2024 · AI
ADJUVANT COMPARISON AND CHARACTERIZATION
$2,797,183Bali Pulendran · Stanford University · N01 · FY2023 · AI
New Scientific Approaches to Facilitate Development of Vaccines
$2,796,534National Institute Of Allergy And Infectious Diseases · Y01 · FY2008 · AI
Advanced Development of Vaccines for Infectious Diseases
$2,795,999Uwe Staerz · Greffex, Inc. · N01 · FY2019 · AI
Novel cell and gene therapy for HIV cure
$2,795,881J. Victor Garcia-Martinez · University Of Alabama At Birmingham · P01 · FY2025 · AI
Mechanisms of naturally-acquired immunity to malaria
$2,795,738Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
$2,794,109Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2025 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$2,792,722Daniel F. Hoft · Saint Louis University · UM1 · FY2025 · AI
Tulane University COVID Antibody and Immunity Network (TUCAIN)
$2,792,292James E Robinson · Tulane University Of Louisiana · U54 · FY2023 · CA
Center for the Analysis & Management of the Multicenter AIDS Cohort Study
$2,791,823Lisa P Jacobson · Johns Hopkins University · UM1 · FY2012 · AI
Center/Coordination, Analysis and Management/MACS
$2,791,823Lisa P Jacobson · Johns Hopkins University · UM1 · FY2012 · AI
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,791,527Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2015 · AI
VTEU: Malaria Vaccine Studies
$2,791,483Karen Kotloff · University Of Maryland Baltimore · N01 · FY2016 · AI
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,791,324Weill Medical College Of Cornell Univ · U01 · FY2000 · HL
MIDAS Center for Communicable Disease Dynamics
$2,791,232Marc Lipsitch · Harvard School Of Public Health · U54 · FY2013 · GM
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$2,790,912Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2021 · AI
Task 02: Manufacture of Influenza for Human Challenge Clinical Trials
$2,789,946Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2018 · AI
SPORE in Gastrointestinal Cancer
$2,788,126Johns Hopkins University · P50 · FY2003 · CA
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$2,787,192Bali Pulendran · Emory University · U19 · FY2014 · AI
Development And Production Of A Multicomponent Ebola rAd Vector Vaccine
$2,785,478Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
$2,785,302Abraham Pinter · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2010 · AI
Tuberculosis Imaging Program
$2,783,766Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,783,692Jeffrey Lennox · Emory University · UM1 · FY2018 · AI